Home
/ 3sbio
/ Competitors

3sbio Competitors and Similar CompaniesClear all

BioNTech's competitors and similar companies include Ultimovacs.

	BioNTech BioNTech is a biotechnology company developing immunotherapies for cancer and infectious diseases.	Ultimovacs Ultimovacs is a pharmaceutical company developing immunotherapies against cancer.
Founding Date	Founding Date 2008	Founding Date 2011
Type	Type Public	Type Public
Tags	Tags Healthcare clinical research drug development oncology	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Mainz, DE HQ Melbourne, AU Wien, AT Shanghai, CN Paris, FR Berlin, DE Berlin, DE see more	Locations Oslo, NO HQ Uppsala, SE
Employees	Employees 6,133	Employees 19
Valuation ($)	Valuation ($) 27.1 b	Valuation ($) 197.3 m
Financial
Revenue (est.)	Revenue (est.) €3.8b (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods €416.4m (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit €3.4b (FY, 2023)	Gross profit N/A
Net income	Net income €930.3m (FY, 2023)	Net income (kr189.2m) (FY, 2023)

For sources of this data, please see the company profile

View Company Profiles

HQ

Oslo, NO

Employees

19

Ultimovacs is a pharmaceutical company developing immunotherapies against cancer.